Photo Release -- Neptune Provides Update on Plant Operating Permits
May 08, 2014 08:00 ET
|
Neptune Technologies & Bioresources Inc
LAVAL, Quebec, May 8, 2014 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (Nasdaq:NEPT) (TSX:NTB), provided an update today on the status of...
Neptune, Acasti and NeuroBioPharm Announce Resignation of Chief Executive Officer
April 28, 2014 08:00 ET
|
Neptune Technologies & Bioresources Inc
LAVAL, Quebec, April 28, 2014 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX:NTB), Acasti Pharma Inc. ("Acasti") (Nasdaq:ACST) (TSX-V:APO) and...
Neptune and Enzymotec Conclude Final Patent Infringement Settlement and License Agreement
April 27, 2014 20:32 ET
|
Neptune Technologies & Bioresources Inc
LAVAL, Quebec, April 27, 2014 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX:NTB) and Acasti Pharma Inc. ("Acasti") (Nasdaq:ACST) (TSX-V:APO), a...
Neptune Obtains New US Patent Relating to Treatment of Alzheimer's
April 24, 2014 12:11 ET
|
Neptune Technologies & Bioresources Inc
LAVAL, Quebec, April 24, 2014 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (Nasdaq:NEPT) (TSX:NTB), announced today that the U.S. Patent &...
Neptune Responds to Enzymotec's Continuous Attempts to Shift Focus From ITC Investigation
April 21, 2014 13:59 ET
|
Neptune Technologies & Bioresources Inc
LAVAL, Quebec, April 21, 2014 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (Nasdaq:NEPT) (TSX:NTB), announced today that the United States Patent...
Neptune Announces Closing of CAD$2.5 Million Private Placement
April 04, 2014 13:36 ET
|
Neptune Technologies & Bioresources Inc
LAVAL, Quebec, April 4, 2014 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (Nasdaq:NEPT) (TSX:NTB), announced today the closing of a private...
Neptune & Acasti Give Update on Patent Litigations With Enzymotec
April 01, 2014 14:24 ET
|
Neptune Technologies & Bioresources Inc
LAVAL, Quebec, April 1, 2014 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX:NTB) and Acasti Pharma Inc. ("Acasti") (Nasdaq:ACST) (TSX-V:APO), a...
Neptune Provides Update on Sherbrooke Plant
March 27, 2014 07:45 ET
|
Neptune Technologies & Bioresources Inc
LAVAL, Quebec, March 27, 2014 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (Nasdaq:NEPT) (TSX:NTB), announced today that reconstruction of its...
NeuroBioPharm Extends Life of Warrants and Provides Other Corporate Updates
March 18, 2014 14:14 ET
|
Neptune Technologies & Bioresources Inc
LAVAL, Quebec, March 18, 2014 (GLOBE NEWSWIRE) -- NeuroBioPharm Inc. ("NeuroBio" or the "Corporation"), a Neptune Technologies & Bioressources Inc. subsidiary ("Neptune") (Nasdaq:NEPT) (TSX:NTB),...
Neptune Announces Pricing of US$25 Million Offering of Common Shares
February 28, 2014 08:33 ET
|
Neptune Technologies & Bioresources Inc
LAVAL, Quebec, Feb. 28, 2014 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (Nasdaq:NEPT) (TSX:NTB), a biotechnology company engaged primarily in the...